Profile
Pattern is a North American immunotherapy company whose systemically-administered TLR4 agonist activates the innate immune system, to address cancers and infectious diseases. Its newly-patented P2PAR product is the next generation of a prior product developed by Pattern principals and approved in ex-US jurisdictions. Pattern has ongoing collaborations with MD Anderson Cancer Center (MDACC) and Massachusetts General Hospital, and plans to commence a Phase 1b clinical study at MDACC in solid tumors in late 2022.
Website
Contact
-
Mark de Groot, Chief Executive OfficerTel: +1 416 302-5155Email: mdegroot@patternpharma.com
-
-
-
-
-
Event details
Date: June 13 - 16, 2022
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
26 in total
-
A4i is a patent pending, validated, digital therapeutic with a regulatory pathway for severe mental illness. A4i's… -
AmacaThera Inc., a clinical-stage company transforming therapeutics to make a difference in patient health. AmacaGel… -
Arbor Life Labs has technology that regulates the Wnt/?-Catenin pathway complemented by modulating disease and tissue… -
Bay Area Health Trust (BAHT) operates and invests in healthcare and life science related companies.… -
Custom Biologics is Canada’s leading regulatory-compliant large molecule CRO. For more than 18 years,… -
Cyclica is the partner of choice for data-driven drug discovery. We advance molecules that embrace the complexity of… -
Dalton Pharma Services is a leading North American cGMP pharmaceutical organization providing integrated drug discovery… -
Environmental Systems Corporation (ESC) designs, manufactures, constructs and validates cleanrooms,… -
Mannin Research Inc. is a Canadian biotechnology company with a subsidiary in Germany, Mannin GmbH. Our… -
Mediphage, a preclinical-stage biotechnology company, is developing a next-generation gene therapy platform based on… -
Nanology Labs is a Canadian biotechnology company focused on advancing the development of T-MX, a first-in-class… -
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP… -
Orange Neurosciences is a rapidly growing multi-product global digital health startup in psychiatry and neurology.… -
Ovensa Inc. works with pharmaceutical companies to enhance the stability and delivery of their RNA… -
panCELLa is a Toronto based biotech company with a focus on gene editing and cellular therapies. panCELLa seeks to… -
Pattern is a North American immunotherapy company whose systemically-administered TLR4 agonist activates the innate…
-
PlantForm develops and manufactures proteins and antibodies using our plant based vivoXPRESS® expression system.… -
Polyanalytik is a contract research laboratory that specializes in the analysis of polymers and biopolymers used… -
ProteinQure is a computational platform for protein drug discovery. We partner with pharma to deliver experimentally… -
PurMinds is an innovative precision NeuroMedicine company pursuing breakthrough solutions to neurodegenerative diseases… -
Spiderwort is a biomaterials company developing cellulose-based scaffolds for use in regenerative medicine. Its lead… -
SQI Diagnostics are leaders in the science of lung health. We develop and manufacture respiratory health and precision… -
Stiris is a Clinical Trial Management company conducting Phase I-IIIB trials for biotech and biopharma. Located in… -
VeriLuce Therapeutics is a research and discovery/early-stage drug development Company focusing on designing and… -
Traditional neurological assessments are slow, subjective, and difficult to do remotely. Winterlight’s technology can…